XERS240719C2000
- 0.35
- 0.000.00%
Xeris Pharmaceuticals Newsroom
Xeris Pharmaceuticals (XERS) Gets a Buy From Craig-Hallum
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS) and Gilead Sciences (GILD)
Xeris Biopharma Holdings Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Xeris Biopharma Holdings, Maintains $6 Price Target
Analysts' Top Healthcare Picks: Phreesia (PHR), Xeris Pharmaceuticals (XERS)
Xeris Pharmaceuticals (XERS) Gets a Buy From Craig-Hallum
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), AMN Healthcare Services (AMN) and 4D Molecular Therapeutics (FDMT)
Piper Sandler: Reiterates the Xeris Biopharma Holdings (XERS.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $4.00 to $3.00.
Xeris Biopharma Holdings Analyst Ratings
Piper Sandler Reiterates Overweight on Xeris Biopharma Holdings, Lowers Price Target to $3
Xeris Pharmaceuticals (XERS) Receives a Buy From Oppenheimer
Strong Operational Performance and Promising Prospects Affirm Buy Rating for Xeris Pharmaceuticals
Craig-Hallum Reaffirms Their Buy Rating on Xeris Pharmaceuticals (XERS)
Craig-Hallum Sticks to Their Buy Rating for Xeris Pharmaceuticals (XERS)
Xeris Biopharma Holdings Analyst Ratings
Oppenheimer Initiates Coverage On Xeris Biopharma Holdings With Outperform Rating, Announces Price Target of $5
Analysts Offer Insights on Healthcare Companies: Applied Therapeutics (APLT), Xeris Pharmaceuticals (XERS) and Arcturus Therapeutics (ARCT)
Xeris Biopharma Holdings Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Aclaris Therapeutics (ACRS) and Quanterix (QTRX)
Analysts Offer Insights on Healthcare Companies: Vaxcyte (PCVX), Xeris Pharmaceuticals (XERS) and IN8bio (INAB)